Pozen Announces Positive Outcome for PA 325
...al study with PA 325 is very encouraging." About pozen pozen is a pharmaceutical company committed to developin...nd chronic pain and other pain-related conditions. pozen has development and commercialization alliances wi...POZEN Announces Positive Outcome for PA 325 Proof of Concept Study
... CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - pozen Inc. (NASDAQ: POZN), today announced top-line resu...al study with PA 325 is very encouraging." About pozen pozen is a pharmaceutical company committed to developin...Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMA
...http://www.gsk.com/">http://www.gsk.com . About pozen pozen is a pharmaceutical company committed to developin..., and/or patient convenience. Since its inception, pozen has focused its efforts primarily on the developme...Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
...http://www.gsk.com/">http://www.gsk.com . About pozen pozen is a pharmaceutical company committed to developin..., and/or patient convenience. Since its inception, pozen has focused its efforts primarily on the developme...Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
... href= "http://www.gsk.com/">www.gsk.com . About pozen pozen is a pharmaceutical company committed to developin..., and/or patient convenience. Since its inception, pozen has focused its efforts primarily on the developme...